Yates Lloyd M sold $2.1M of MRSH

Yates Lloyd M sold 12,000 shares of MARSH & MCLENNAN COMPANIES, INC. (MRSH) at $175.65 ($2.11M total) on 2026-07-23.

Original reporting
SEC EDGAR · Yates Lloyd M
Published Jul 24, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 24, 2026, 8:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MRSH
Neutral
medium confidence
Mentioned
$MRSH
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MRSHNeutralLow
01

Why it matters

The newest fact is the director’s open-market sale details (shares, price, total value, post-transaction holdings).

02

Market read

Traders may note the sale for sentiment monitoring, but there is no accompanying company-specific catalyst in the text.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs; without additional context or repeated sales, signal quality is low.

Relevance 6/10Novelty 3/10Timing: Filed 2026-07-24, discloses sale executed 2026-07-23.

Background

The article is a SEC Form 4 insider transaction disclosure for Marsh & McLennan (MRSH).

Company-level read

Ticker impact

$MRSHNeutralMedium confidence
Context

Marsh & McLennan director Yates Lloyd M sold 12,000 shares on 2026-07-23 at $175.65, totaling $2.11M, per Form 4.

Expected impact

Likely limited near-term impact; treat as routine insider liquidity unless follow-on filings suggest broader selling.

Evidence & confidence

The article provides a single Form 4 sale with no 10b5-1 plan and no accompanying company-specific news, so the incremental trading signal is modest.

Market effects

No sector read-across is provided; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Absence of a 10b5-1 plan could be interpreted as less “mechanical” selling, but the filing alone does not establish intent or future sales.

Key entities

  • Marsh & McLennan Companies, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Yates Lloyd M

    Director who sold 12,000 shares on 2026-07-23.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MRSHMedAI 8/10

Marsh acquires Wilshire to deepen wealth advisor reach

Marsh (NYSE: MRSH) agreed to acquire Wilshire, a firm managing $221B in assets and advising on $1.6T, to expand its wealth advisor reach. Wilshire's capabilities in alternatives, model portfolios, and data analytics will bolster Marsh's offerings. The deal is expected to close in Q1 2027, with terms undisclosed.

$MRSHHighAI 9/10

Marsh agrees to buy Wilshire adding USD221bn in AUM and a big step into wealth

Marsh (NYSE: MRSH) agreed to acquire Wilshire, adding $221bn in AUM and expanding into wealth management. The deal, expected to close in Q1 2027, strengthens Marsh's offerings for institutional and wealth clients. Wilshire advises on over $1.6tn in assets. Marsh recently acquired AltamarCAM and launched Marsh BrightPath, signaling expansion in private markets and retirement.